Drugs / Adipose Derived (AD) Stromal Vascular Fraction (SVF)
Adipose Derived (AD) Stromal Vascular Fraction (SVF)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05515523 | Feb 2026 → Nov 2027 | osteoarthritis | Wake Forest University Health Sciences | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adipose Derived (AD) Stromal Vascular Fraction (SVF) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05515523 ↗ |
| Modality | Cell therapy | “autologous stromal vascular fraction cells from adipose tissue for reintroduction to the same patient” NCT05515523 ↗ |
| Route | Other | “Intra-articular Stromal Vascular Fraction” NCT05515523 ↗ |